Related Experiment Videos

[Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age]

P Ferrara1, A Ruggiero, S Pulitanò

  • 1Istituto Clinica Pediatrica, Università Cattolica del Sacro Cuore, Roma.

Minerva Pediatrica
|April 22, 1999
PubMed

Insights

Dyslipidemia, or abnormal blood lipids, is linked to cardiovascular issues from childhood. Early detection and management in children with kidney disease are crucial for preventing complications and preserving kidney function.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Science
  • Metabolic Disorders

Context:

  • Atherosclerosis begins in childhood, with dyslipidemia strongly correlating to cardiac and cerebrovascular events.
  • Systemic diseases and genetic factors can disrupt lipid metabolism, leading to clinical dyslipidemia.
  • Kidney disease significantly impacts lipid homeostasis and increases cardiovascular risk, especially in end-stage renal disease.

Purpose:

  • To highlight the critical importance of assessing lipid profiles in children, particularly those with renal disease.
  • To underscore the link between lipid anomalies and the progression of renal failure.
  • To emphasize the role of early intervention in preventing atherosclerotic events in pediatric patients with kidney conditions.

Summary:

  • Lipid pattern analysis is essential in pediatric patients with renal disease due to their heightened risk of progressive renal failure.
  • Children with nephrotic syndrome, renal failure, or post-transplantation often exhibit elevated triglycerides, cholesterol, LDL, and VLDL.
  • Identifying and addressing lipid abnormalities is vital for mitigating cardiovascular risks and slowing renal damage progression.

Impact:

  • Early detection and management of dyslipidemia in pediatric kidney disease can prevent severe cardiovascular complications.
  • Understanding lipid metabolism in renal disease aids in developing targeted therapies to preserve kidney function.
  • Proactive pharmacological and dietary interventions are key to preventing atherosclerotic events and improving long-term outcomes in affected children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...